bioavailability study

Showing 1 - 4 of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bioavailability Study Trial in Ghent (MP29-02, Fluticasone propionate)

Withdrawn
  • Bioavailability Study
  • Ghent, Belgium
    University Hospital Ghent, departement otorhinolaryngology
Jul 7, 2021

Bioavailability Study Trial in Hefei (Hetrombopag)

Completed
  • Bioavailability Study
  • Hefei, Anhui, China
    The Second Hospital of Anhui Medical University
Feb 24, 2021

Bioavailability Study Trial in Groningen (ARGX-113)

Completed
  • Bioavailability Study
  • Groningen, Netherlands
    QPS Netherlands B.V.
Aug 28, 2020

Bioavailability Study Trial in Miami (NPC-12G Gel 0.2%, Rapamune® 2 mg tablet)

Completed
  • Bioavailability Study
  • NPC-12G Gel 0.2%
  • Rapamune® 2 mg tablet
  • Miami, Florida
    InVentiv Health Clinical Research Services LLC
Mar 4, 2020